JP Morgan Chase’s Genelux GNLX Stock Holding History
Bought
Maintained
Sold
Other funds holding GNLX
CM
JP Morgan Chase's GNLX Position: Q3 2026 in Review
JP Morgan Chase increased its Genelux (GNLX) stake by 58% in Q3 2026, buying an estimated $41 and bringing the position to 41 shares worth $101. The position accounts for ﹤0.01% of the portfolio, ranked #7834.
JP Morgan Chase first reported a position in GNLX in Q1 2023 and has held it in 15 quarters since. The position peaked at $308K in Q3 2023. 64 funds tracked by Wall St. Rank hold GNLX as of Q3 2026.
- JP Morgan Chase held 41 shares of Genelux worth $101 as of Q3 2026.
- JP Morgan Chase bought 15 Genelux shares in Q3 2026, an estimated $41.
- Genelux made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #7834 holding.
- JP Morgan Chase first reported a position in Genelux in Q1 2023 and has held it in 15 quarters since.
- JP Morgan Chase's Genelux position peaked at $308K in Q3 2023.
- 64 funds tracked by Wall St. Rank held Genelux as of Q3 2026.
Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.